top of page
ERESDiagram_edited_edited_edited_edited_
ERES HighRes 2 - smaller TM_edited_edite

Democratizing Advanced Endoscopy

ERES™ is under development and is not authorized to be marketed or sold in any market.

The Clinical Challenge for Colorectal Cancer Treatment

​Endoscopic Submucosal Dissection (ESD) is the preferred advanced endoscopic technique for removing early colorectal cancers endoscopically but requires highly specialized skills.


Due to the technical difficulty of ESD, most patients undergo more invasive procedures (e.g., laparoscopic or open surgery), leading to longer recovery times, increased costs, and higher procedural risks.


In some cases, a colectomy (remove of all or part of the colon) is required, which may necessitate the creation of a stoma in the abdominal wall and use of a stoma bag.

Conventional Endoscopic Submucosal Dissection (ESD)

eyJwYXRoIjoiaWhoLWhlYWx0aGNhcmUtYmVyaGFk

ERES™ Endoscopic Robot – A Solution for Wider ESD Adoption

A minimally-invasive surgical robotic system that integrates seamlessly with all existing conventional endoscopes. Designed for seamless clinical adoption - leveraging standard endoscopic tools, with added robotic automation for enhanced precision and control.

 

Intuitive and easy to use, enabling clinicians, regardless of prior ESD experience, to perform advanced endoscopic procedures with minimal training whilst maximising cost-effectiveness.

 

Removal of early colorectal cancers via robotic ESD with the ERES™ endoscopic robot will be as simple and straightforward as a standard colonoscopy - with faster patient recovery, shorter hospital stays and more optimal clinical outcomes.

Developed alongside Clinical & Technical Experts

To ready the ERES™ Endoscopic Robot for market whilst ensuring clinical efficacy  and technical superiority, Vivo Surgical has partnered with

 

  • Renowned therapeutic endoscopists from world-leading health systems across the USA and the Asia Pacific

  • Expert medical technologists from multinational strategics and technology incubators​​

*From August 2025 onwards.

Screenshot 2025-07-08 181955.png

*

ERES™ is under development and is not authorized to be marketed or sold in any market.

bottom of page